AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia

NCT07030595 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

474

Enrollment

INDUSTRY

Sponsor class

Conditions

ESRD (End Stage Renal Disease)
Chronic Kidney Disease(CKD)
Hyperphosphatemia
Hyperphosphatemia in Chronic Kidney Disease
Dialysis
Chronic Kidney Disease, Receiving Dialysis

Interventions

DRUG: AP301
DRUG: Sevelamer carbonate (Renvela®)
DRUG: AP301 Low Dose

Sponsor

Alebund Pharmaceuticals